GLP-1R Race in 2025: 8 Essential Takeaways Drug Developers Need to Know Currently Playing Post:GLP-1R Race in 2025: 8 Essential Takeaways Drug Developers Need to Know In late 2025, a seemingly narrow advertising dispute told a much bigger story about the GLP-1 market
Extensive blood tests, including coagulation studies, were performed and were normal
In terms of effectiveness, head-to-head and real-world comparative data generally favour Mounjaro
Both are powerful brightening agents, but they target dullness, uneven skin tone, dark spots, and acne marks in distinct ways
Startpage To view or add a comment, sign in I just read Jeffrey Mard's recap from last week's Connected: Health & Fitness Summit
While Wegovy is not expected to cause withdrawal symptoms, stopping the medication may lead to a loss of its cardiovascular and weight management benefits